TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
SRRK

Scholar Rock Holding Corp

Healthcare · Biotechnology

46.70$ -4.8% vs. previous close Closing price · As of: Sep 18, 2026

Investor relations

Report Dates

Investor relations overview for Scholar Rock Holding Corp (SRRK): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 08/06/2026.

Next report 08/06/2026
Last report 08/06/2026
Earnings surprise by quarter (%)
Q3 23 · -3.9 % 23 Q4 23 · -2.0 % 23 Q1 24 · -15.7 % 24 Q2 24 · -1.7 % 24 Q3 24 · -11.9 % 24 Q4 24 · 3.0 % 24 Q1 25 · 5.6 % 25 Q2 25 · -46.3 % 25 Q3 25 · -7.1 % 25 Q4 25 · 2.0 % 25 Q1 26 · -6.4 % 26 Q2 26 · 0.0 % 26

EPS estimate beaten

Full history 13 of 35 quarters (37%)
Last 16 quarters 7 of 16 quarters (44%)

Earnings Call Transcripts

Search all transcripts →

  • 08/06/2026 Earnings Call Q2 2026 Open →
  • 05/07/2026 Earnings Call Q1 2026 Open →
  • 03/03/2026 Earnings Call Q4 2025 Open →
  • 11/14/2025 Earnings Call Q3 2025 Open →
  • 08/06/2025 Earnings Call Q2 2025 Open →
  • 05/14/2025 Earnings Call Q1 2025 Open →
  • 02/27/2025 Earnings Call Q4 2024 Open →
  • 11/12/2024 Earnings Call Q3 2024 Open →
  • 08/08/2024 Earnings Call Q2 2024 Open →

News on This Stock

  • 09/15/2026 Scholar Rock Holding Corp (SRRK): Regulation FD Disclosure · sec.gov Open ↗
  • 09/14/2026 Scholar Rock Holding Corp (SRRK): Regulation FD Disclosure; Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Scholar Rock Holding Corp (SRRK): Other Events; Financial Statements and Exhibits · sec.gov Open ↗
  • 08/06/2026 Scholar Rock Holding Corp (SRRK): Results of Operations and Financial Condition · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?